Background: Essential hypertension is a prevalent complex polygenic disease and a major risk factor for cardiovascular disease, the leading cause of death in developed countries. Because of its complex and multifactorial nature, its genetic determinants still remain largely unknown. The Dahl saltsensitive hypertensive rat model exhibits impaired sodium handling, which is hypothesized to play a key role in the pathophysiology of polygenic hypertension. Thus, genes associated with renal regulation of salt and water balance are a priori likely candidates for a causative role in hypertension pathogenesis. The functional properties and renalspecific expression of the recently characterized AngII/AVP receptor suggest a putative modulator role in tubular sodium and fluid reabsorption. Based on these observations, we investigated the potential involvement of the AngII/AVP receptor in salt-sensitive hypertension.
Introduction
The kidney plays a primary role in hypertension pathogenesis in the Dahl salt-sensitive hypertensive rat model (1) (2) (3) . Transplant studies have shown that the donor kidney determines the blood pressure phenotype in the bilaterally nephrectomized recipient (3) . A similar situation has also been described in human renal transplant patients (3) . These facts validate the analysis of genes expressed preferentially within the kidney as logical candidates for hypertension-susceptibility genes. Because the AngII/ AVP receptor is prominently expressed in renal epithelial cells (4, 5) , and both AngII and AVP hormones are both known to modulate tubular sodium and fluid reabsorption (6) (7) (8) (9) (10) (11) (12) (13) (14) , we investigated whether this receptor could have a potential role in hypertension pathogenesis. The AngII/AVP receptor is coupled to adenylate cyclase and responds with equal sensitivity to AngII and AVP (4) . Pharmacologic characterization defines this dual receptor as a novel AT 1 /V 2 type of receptor (5) . These receptor properties, in conjunction with its renal immunocytochemical distribution to the outer medullary thick ascending limb tubules and inner medullary collecting ducts (5) , suggest that the AngII/AVP receptor could play a prominent role in renal tubular sodium and fluid reabsorption. Thus, it is intriguing to hypothesize that this dual receptor could mediate the coordination of two distinct blood pressure regulatory systems.
To assess the putative role of the AngII/AVP receptor in hypertension pathogenesis, we performed genetic and molecular analyses in the Dahl S/Dahl R rat genetic model of salt-sensitive hypertension. The results reported here strongly suggest that the AngII/AVP receptor is a hypertension-susceptibility gene in the Dahl S rat model, thus providing impetus for the future investigation of its potential role in human essential hypertension.
Materials and Methods

Chromosomal Localization of the AngII/AVP Receptor Gene
To localize the AngII/AVP receptor gene within the rat genome, we conducted a radiation hybrid panel screening on a rat panel (Rat/Hamster RH panel RH07) obtained from Research Genetics (Huntsville, AL, USA). A 479-bp polymerase chain reaction (PCR) fragment (upstream primer: 5'-gtt-aca-gag-ctg-agggcc-tg-3'; downstream primer: 5'-cct-gga-aac-cacact-cac-ct-3') from the 5' regulatory region of the rat AngII/AVP receptor gene was utilized as indicator product. The data were then tested against the existing framework maps. The results assign the AngII/AVP receptor gene to chromosome 1, 14.6 cR from D1Rat111 with a LOD ϭ 24.673. This places the AngII/AVP receptor gene approximately 1.7 cM centromeric to D1Rat188 (Table 1) .
Intercross Linkage Analysis
The development of the (Dahl S/Hsd ϫ Dahl R/Hsd) F2 male cohort and phenotypic characterization has been described previously (15) . Blood pressure measurements were obtained by radiotelemetry after 8 weeks of high salt (8% NaCl) challenge. Genotyping was performed using the following microsatellite markers: D1Rat68, D1Rat129, D1Rat188, D1Mgh11, D1Rat298, D1Rat371, D1Rat77, D1Rat304, and D1Rat122 obtained from Research Genetics. Linkage maps and QTL analysis were done with the Map Manager QTXb08 (MMQTX08) program for windows (16) , which generates a likelihood ratio statistic (LRS) as a measure of the significance of a possible QTL. Genetic distances were calculated using Kosambi mapping function (genetic distances are expressed in cM) and were as follows:
Critical significance (LRS) values for interval mapping were determined by a permutation test (2000 permutations at 5-cM intervals) on our 105 informative progeny using Kosambi mapping function and a constrained additive regression model. Thus, the minimum LRS values were 1.4 for suggestive, 6.6 for significant, and 12.2 for highly significant.
cDNA Library Screening and Nucleotide Sequencing
Dahl S/JR and Dahl R/JR rat kidney gt11 cDNA libraries (17) were screened with the full-length Sprague-Dawley AngII/AVP receptor cDNA (4). Several Dahl S and Dahl R AngII/AVP receptor 
Results
Intercross Linkage Analysis
To assess the potential genetic contribution of the AngII/AVP receptor gene to salt-sensitive hypertension susceptibility, we performed an intercross linkage analysis on 105 F2 (Dahl S ( ϫ Dahl R &) hybrid male rats phenotyped for BP by radiotelemetry after 8 weeks of high salt (8% NaCl) challenge (15) . We localized the AngII/AVP receptor gene to rat chromosome 1, 1.7 cM centromeric to the D1Rat188 marker (see Table 1 ) by radiation hybrid mapping analysis. Thus, 105 F2 male hybrids were genotyped at nine informative markers that spanned the AngII/AVP receptor locus on chromosome 1. As seen in Table 1 , LRS and p values peaked at D1Rat188 (the closest marker, 1.7 cM to the AngII/AVP receptor locus) for SBP (LRS ϭ 13.8, p ϭ 0.00020), DBP (LRS ϭ 8.6, p ϭ 0.00336), and MAP (LRS ϭ 12.4, p ϭ 0.00043). These results fulfill the first of four criteria needed to identify a hypertension susceptibility gene (15, 20) : 1) association of the putative hypertension susceptibility gene with hypertension in validated genetic animal models or human hypertensive patients, 2) identification of a functionally significant structural mutation in the relevant gene, 3) concordance of the observed molecular dysfunction with a pathophysiologic mechanism logical to the cDNAs were isolated. A Dahl S cDNA (ϳ1.9 kb) and a Dahl R cDNA (ϳ1.6 kb) were subcloned into psp73 transcription vector (Promega, Madison, WI, USA) and sequenced in their entirety by the Sanger dideoxy-chain termination sequencing method using Sequenase (U.S. Biochemical, Cleveland, OH, USA) as described previously (17) . All sequences were confirmed on both strands.
Detection of the N119S and C163R Mutations by Using the Amplification Refractory Mutation System (ARMS)
The ARMS was performed using genomic DNA isolated from three Dahl S/Hsd and two Dahl R/Hsd rats essentially as described (18) . The downstream primer (5'-tgc-aca-ctt-cct-gcg-ga-AC-3', Dahl S specific) specific for the N119S mutation was "destabilized" by introducing a G/A transition 1 nucleotide upstream of the 3'-OH mismatched C residue. Detection of allelespecific amplified products (102 bp) was done by 32 Pend labeling the upstream primer (5'-cac-cta-cca-gttcat-tga-cc-3') and subsequent size fractionation on a 6% denaturing polyacrylamide gel. The optimal stringent PCR cycling conditions experimentally determined for the N119S mutation detection were as follows: 95ЊC for 10 min; 35 cycles of 94ЊC ϫ 30 sec, 57ЊC ϫ 30 sec, 72ЊC ϫ 1 min; and extension at 72ЊC ϫ 7 min. The downstream primer (5'-cac-gcc-ctg-gca-ccaca-TG-3', Dahl S specific) specific for the C163R mutation was "destabilized" by introducing a C/T transition 1 nucleotide upstream of the 3'-OH mismatched G residue. Detection of allele-specific amplified products (131 bp) was done by 32 P-end labeling the upstream primer (5'-atg-ctc-ctg-aac-tct-gac-g-3') and subsequent size fractionation on a 6% denaturing polyacrylamide gel. The optimal stringent PCR cycling conditions experimentally determined for the C163R mutation detection were as follows: 95ЊC for 10 min; 35 cycles of 94ЊC ϫ 30 sec, 55ЊC ϫ 30 sec, 72ЊC ϫ 1 min; and extension at 72ЊC ϫ 7 min. Reaction volumes were 10 L, using 0.05 mol/L of each primer for the C163R substitution and 0.6 mol/L of each primer for the N119S substitution, 0.5 U/10 L of AmpliTaq Gold (Perkin-Elmer, Branchburg, NJ, USA), 1.5 mM MgCl 2 , and 0.2 g of genomic DNA. As control, the D1Mit13 marker (320 bp, not polymorphic between Dahl S and Dahl R strains) was used to assess equivalent amounts of genomic DNA in the different samples. To demonstrate equivalent amounts of cloned Dahl S and Dahl R AngII/AVPr cDNAs, we used a 260-bp PCR product encompassing nucleotides 378-638 (forward primer: 5'-gtt-cat-tga-cca-gag-cttcc-3'; reverse primer: 5'-ctt-tgt-cct-tgt-acc-cac-c-3') of the published Sprague-Dawley AngII/AVPr cDNA (4).
Functional Analysis
The Dahl S and Dahl R AngII/AVP receptor cDNAs were subcloned directionally (5' to 3') into the NheI site of the pMAMNeo expression vector (Clontech, Palo Alto, CA, USA). Stable Cos1 neomycin-resistant transfectants were developed as described (4 
To assess putative additional functional differences between the Dahl S and Dahl R AngII/AVP receptors, both expression vectors (pMAM-Dahl S AngII/AVPr and pMAM-Dahl R AngII/AVPr) were transfected into C127 cells (mouse mammary tumor cell line [ATCC]), respectively, and membranes were isolated from transient transfectants and assayed for AVP-and AngII-induced cAMP accumulation. In earlier xenopus oocyte microinjection expression experiments, we noticed a pronounced effect of NaCl on the AngII-induced cAMP accumulation in isolated oocyte membrane preparations (unpublished results). Thus, we evaluated the effect of different NaCl concentrations on the AVP-and AngII-induced cAMP accumulation by the Dahl S and Dahl R receptors. As shown in Figure 3 , striking differences can be observed between the Dahl S and Dahl R expressed AngII/AVP receptors. First, upon addition of 50 mM of NaCl, the AVP-induced cAMP accumulation increased by 14% over control levels (at 0 mM of NaCl) in Dahl R AngII/AVP receptor expressing membranes (from 150 Ϯ 7 pmol/mg Mb to 171 Ϯ 8 pmol/mg Mb). In contrast, the addition of 50 mM of NaCl produced an exaggerated response with a far greater increase (182%) in AVP-induced cAMP accumulation in Dahl S AngII/AVP receptor expressing membranes over control levels (0 mM of NaCl; from 123 Ϯ 6 pmol/mg Mb to 347 Ϯ 12 pmol/mg Mb, Fig. 3a) . Similarly, a greater response (209%) to AngII was also observed in Dahl S versus Dahl R AngII/AVP receptor expressing membranes in the presence of 50 mM of NaCl (170 Ϯ 11 pmol/mg Mb versus 55 Ϯ 4 pmol/mg Mb, Fig. 3b) , respectively. This differential response is not due to differences in receptor density; similar, if not higher, AVP response (123 Ϯ 6 pmol/mg Mb in Dahl S versus 150 Ϯ 7 pmol/mg Mb in Dahl R membranes) can be observed in Dahl R AngII/AVP receptor expressing membranes under control conditions (at 0 mM NaCl; Fig. 3 ). hypertension pathogenesis, and 4) delineation of the mechanistic role in an in vivo model. Based on a permutation test performed on the 105 informative progeny that established the minimum LRS value for highly significant as equal to 12.2, the AngII/AVPr locus exhibits a highly significant linkage with SBP (LRS ϭ 13.8). Analysis for interaction with ␣1 Na,K-ATPase, bumetanide-sensitive Na,K,2Cl-cotransporter and thiazide-sensitive Na, Cl-cotransporter loci were negative. As shown in Table 1 , the AngII/AVP receptor locus accounts for 12% of the SBP variance.
Molecular Analysis
To identify molecular variants of the AngII/AVP receptor that could account for the cosegregation of the AngII/AVP receptor locus with salt-sensitive hypertension in the Dahl S rat model, we screened Dahl S and Dahl R rat kidney gt11 cDNA libraries with the full-length Sprague-Dawley AngII/AVP receptor cDNA (4) as probe. Several cDNA clones were isolated and characterized. The entire amino acid coding region for both Dahl R and Dahl S receptors were obtained, revealing three nucleotide differences between the Dahl R and Dahl S AngII/AVP receptor cDNAs (Fig. 1) . Two of the nucleotide changes resulted in amino acid substitutions: A 356 (Dahl R) → G 356 (Dahl S) nucleotide transition resulting in N119S substitution localized in the first intracellular loop (Fig. 1b) ; T 487 (Dahl R) → C 487 (Dahl S) nucleotide transition resulting in C163R substitution localized to the second extracellular loop (Fig. 1b) . The third A 627 (Dahl R) → G 627 (Dahl S) nucleotide transition did not change the encoded amino acid. The nucleotide sequence encompassing the entire amino acid coding region of the Dahl R cDNA was identical to the previously reported Sprague-Dawley AngII/AVP receptor cDNA (4) . The presence of N119S and C163R mutations in Dahl S and its absence in Dahl R rat genomic DNA was corroborated by error-independent amplification refractory mutation system (ARMS) detecting G 356 and C 487 in Dahl S in contrast to non-G 356 and non-C 487 in Dahl R rat genomic DNA, respectively (Fig. 1c) .
To elucidate potential functional differences between the Dahl S and Dahl R AngII/AVP receptors, both molecular variants were expressed in tissue culture and assayed in ligand binding experiments and hormone-dependent activation of adenylate cyclase. For this purpose, the Dahl S and Dahl R cDNA clones containing the full-length amino acid coding region of the AngII/AVP receptor were subcloned directionally (5'→3') into the NheI site of the pMAM expression vector (Clontech). Both expression vectors (pMAM-Dahl R AngII/AVPr and pMAM-Dahl S AngII/AVPr) were then permanently transfected into Cos1 cells, and subsequently assayed for receptor function. Saturation binding studies using 125 I-AngII and 3 H-AVP on intact (c) Detection of the N119S and C163R mutations in genomic DNA by using the amplification refractory mutation system (ARMS). ARMS analysis was designed to detect the Dahl S AngII/AVP receptor gene variant, when present, by the production of an expected 102-bp (for the N119S substitution) and a 131-bp (for the C163R substitution) product, respectively. Analysis was done on three Dahl S (S1, S2, and S3) and two Dahl R (R1 and R2) genomic DNAs. Controls for the ARMS analysis were cloned Dahl S (S) and cloned Dahl R (R) AngII/AVPr cDNAs at four copies per genome equivalent. The 260-bp fragment corresponds to control PCR product showing equivalent amounts of cloned Dahl S and Dahl R AngII/AVPr cDNAs. The 320-bp fragment corresponds to control PCR product ascertaining that all genomic DNA samples amplify equivalently. The ARMS test readily detects G 356 and C 487 in Dahl S genomic DNA and their absence in Dahl R genomic DNA.
Discussion
Our studies have detected a modulator effect of sodium on G-protein coupling, a unique feature of the AngII/AVP receptor function that could have a significant impact on modulation of receptor function under physiologic conditions. Whereas AVP-dependent activation of cAMP accumulation (presumably via G s -receptor coupling) is minimally affected by sodium in the wild-type (Dahl R) receptor, the AngII-dependent activation of cAMP accumulation is dramatically influenced by sodium in both Dahl S and Dahl R receptors resulting in a dichotomous sodium effect. Inhibition of AngII-induced cAMP accumulation (presumably via G i -receptor coupling) is observed in the absence of sodium, whereas stimulation of AngII-induced cAMP accumulation (presumably via G s -receptor coupling) is observed in the presence of sodium (see Fig. 3 ).
Sodium modulation of receptor function is not without precedent. Allosteric regulation of ␣2-adrenergic receptor ligand binding by sodium has been reported (21) in which the allosteric effects of sodium have been found to be maximal at 40 mM (21) . This is similar to the maximal effect of sodium on AngII/AVP receptor function detected at 50 mM (see Fig. 3 ). Altogether, the data suggest that the sodium modulation of AngII/AVP receptor function is a biologically significant phenomenon that contributes to susceptibility to salt-sensitive hypertension in the Dahl S rat model. Furthermore, we hypothesize that this receptor could be a key component of a sodium-sensing gene network underlying physiologic regulation of sodium homeostasis. It is important to note that the AngII/AVP receptor is broadly expressed in neurons of the central nervous system, including those regions thought to be involved in central control of blood pressure and salt appetite (22, 23) . However, additional molecular, cellular, and physiologic studies are necessary to test this hypothesis.
The differential effects of sodium on AngII-and AVP-induced cAMP accumulation indicate that the AngII/AVP receptor mediates AngII and AVP stimulation via two distinct effector pathways. Moreover, it also documents alternative use of guanine nucleotidebinding regulatory proteins by a single receptor as a mechanism for diversifying receptor function. The sodium-dependent "switching" of the AngII/AVP receptor from G i to G s coupling observed in our studies, resembles the PKA-dependent "switching" from G s to G i coupling recently reported in the ␣2-adrenergic receptor (24) , thus corroborating the existence of multiple G-protein coupling "switching" mechanisms.
The localization of the amino acids substitutions within the Dahl S receptor suggests that they may differentially influence receptor function. The N119S substitution in the H2-H3 intracellular loop (see Fig. 1b ) could affect G S coupling because of its proximity to the putative G S activation domain (H4-H5 intracellular loop, see Fig. 1b ). In contrast, the C163R substitution in the H3-H4 extracellular loop (see Fig. 1b ) might influence AVP and AngII binding due to its putative effects on the secondary structure of the extracellular receptor domains.
Our results demonstrate the existence of a "hyperfunctioning" AngII/AVP receptor present in Dahl salt-sensitive rats exhibiting increased affinity for both ligands (AVP and AngII) and enhanced G S coupling resulting in increased activation of adenylate cyclase. Analogous dysfunctional behavior has been reported for the constitutively activated mutation of the luteinizing hormone receptor in familial male precocious puberty (25) and in thyrotropin receptor involved in thyroid adenomas (26) . Thus, for any given level of ligand (AVP or AngII) concentrations, the "hyperfunctional" Dahl S AngII/AVP receptor will effectively produce a higher level of cAMP accumulation compared with the Dahl R receptor. Intuitively, we hypothesize that this AngII-AVP "hyperresponse" could contribute to increased tubular sodium and fluid reabsorption in Dahl S rats, a characteristic pathophysiology observed in this genetic hypertensive rat model (3). Our hypothesis is substantiated by the prominent expression of the AngII/AVP receptor in the thick ascending limb of the loop of Henle and collecting ducts (5) .
We note that several genetic studies in different rat models have documented a chromosome 1 quantitative trait locus (QTL) in the region spanning the AngII/AVP receptor locus for high blood pressure (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . Reports include intercross linkage analysis of F2 cohorts derived from SHRSP (stroke-prone spontaneously hypertensive rat) ϫ WKY (WistarKyoto normotensive rat) (27, 28) , SHR (spontaneously hypertensive rat) ϫ WKY (29) , SS/JR (Dahl saltsensitive hypertensive rat) ϫ LEW (Lewis normotensive rat) (32), FHH (Fawn-hooded hypertensive rat) ϫ ACI (ACI normotensive rat) (31) and SBH/y (saltsensitive Sabra hypertension-prone rat) ϫ SBN/y (salt-resistant Sabra hypertension resistant rat) (37) . Based on recent evidence excluding Sa as a candidate gene for the blood pressure QTL on rat chromosome 1 (35, 36) , our results, in conjunction with the available genetic evidence, point to the AngII/AVP receptor as the candidate gene for the chromosome 1 QTL in different rat models of essential hypertension. Strategic transgenic experiments will be necessary to demonstrate the mechanistic role of the AngII/AVP receptor in salt-sensitive hypertension.
Most importantly, the selective AngII-dependent sodium hyperresponsiveness of the dual AngII/AVP receptor is concordant with studies in humans demonstrating the central role of the renin-angiotensin system (RAS) in salt-sensitive blood pressure response (38) . Altogether the data provide a compelling basis and strategic focus for investigating the role of the AngII/AVP receptor in human hypertension.
